Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
David Rubin, MD
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
Brooke Hodnick, PA-C, MPAS
Switching Strategies: Switch or Stay—What’s Your Call?
Remission: Can You Prove It?
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
Linda Stein Gold, MD
Bruce Strober, MD, PhD
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
Pushpa Narayanaswami, MD, FAAN
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
A.J. Gelderblom, MD, PhD
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Michiel van de Sande, MD, PhD
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
Chelsea Cole, MD
Treat-to-Target: Are We There Yet?
Severity Assessment: Can You Pin the Stage on the Patient?
Tailoring Treatment: Can You Select the Best Therapy?
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
Case Review: Can You Crack This IBD Case?
Case Review: Targets Are Met—Can You Stick the Landing?
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MOA: CDH6-Targeted Antibody-Drug Conjugates
Kathleen Moore, MD, MS
IBD Immunopathogenesis: Do You Know What You're Blocking?
Taking Action Against RSV: No Child Unprotected
Tina Q. Tan, MD
Yvonne Maldonado, MD
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
April W. Armstrong, MD, MPH
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
Joyce F. Liu, MD, MPH
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.